Drug Shortage Report for METHOTREXATE INJECTION USP
| Report ID | 64245 |
| Drug Identification Number | 02398427 |
| Brand name | METHOTREXATE INJECTION USP |
| Common or Proper name | METHOTREXATE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 2MLx1 VIAL |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-09-28 |
| Estimated end date | Unknown |
| Actual end date | 2023-07-07 |
| Shortage status | Resolved |
| Updated date | 2023-11-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-12-13 | French | Compare |
| v3 | 2018-12-13 | English | Compare |
| v2 | 2018-10-15 | French | Compare |
| v1 | 2018-10-15 | English | Compare |